首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
NivolumabBullous pemphigoid: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2017年
/ 1674卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-017-37680-x
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:220 / 220
相关论文
共 50 条
[41]
SaxagliptinBullous pemphigoid: case report
Reactions Weekly,
2022,
1900
(1)
: 302
-
302
[42]
RifampicinBullous pemphigoid: case report
Reactions Weekly,
2016,
1607
(1)
: 368
-
368
[43]
PembrolizumabBullous pemphigoid: case report
Reactions Weekly,
2020,
1791
(1)
: 208
-
208
[44]
SitagliptinBullous pemphigoid: case report
Reactions Weekly,
2022,
1907
(1)
: 434
-
434
[45]
TozinameranBullous pemphigoid: case report
Reactions Weekly,
2022,
1895
(1)
: 352
-
352
[46]
AtezolizumabBullous pemphigoid: case report
Reactions Weekly,
2025,
2056
(1)
: 77
-
77
[47]
CemiplimabBullous pemphigoid: case report
Reactions Weekly,
2022,
1916
(1)
: 140
-
140
[48]
AdalimumabBullous pemphigoid: case report
Reactions Weekly,
2021,
1853
(1)
: 16
-
16
[49]
PembrolizumabBullous pemphigoid: case report
Reactions Weekly,
2017,
1653
(1)
: 256
-
256
[50]
PembrolizumabBullous pemphigoid: case report
Reactions Weekly,
2021,
1853
(1)
: 387
-
387
←
1
2
3
4
5
→